Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection
Jessica S Little(Brigham and Women's Hospital), Graham F. Hatfull(University of Pittsburgh), Tulip A. Jhaveri(University of Mississippi Medical Center), Daniel A. Solomon(Brigham and Women's Hospital), Krista G. Freeman(University of Pittsburgh), Constance A. Benson(University of Colorado Health), Bailey E. Smith(University of Pittsburgh), Madison Cristinziano(University of Pittsburgh), Lindsey R. Baden(Brigham and Women's Hospital), Rebekah M. Dedrick(University of Pittsburgh)
Cited by 130
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981